Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
HomeScreenerChatCompanies
Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
Companies/Precipio, Inc.
Company profile

Precipio, Inc.

NASDAQ: PRPO · Healthcare · Medical - Diagnostics & Research
PublicHQ New Haven, CT · New HavenCIK 0001043961Reports USD
#524 of 1,394 Healthcare companies by revenue72nd-percentile growth
EA Score
70B
FH 73DQ 66GM 75SS 52
v0.1 · 65/100 weight · provisional
↑ disclosure history, Piotroski F · ↓ filing timeliness, listing tenure
Methodology →
Revenue TTM
$26.1M
Rev growth YoY (TTM)
+34.8%
Net income (FY)
-$363.0k
Employees
54
Market cap
$45.1M
OverviewFinancialsSegmentsFilingsESGPeople & Places

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$24.2M$24.2M2025
Net income-$363.0k-$363.0k2025
Operating income-$1.2M-$1.2M2025
Total assets$21.3M$21.3M2025
Liabilities$6.8M$6.8M2025
Equity$14.6M$14.6M2025

Revenue trend

FY2018 – FY2025 · USD
$3.4M
FY18
$4.1M
FY19
$7.4M
FY20
$8.7M
FY21
$9.8M
FY22
$15.4M
FY23
$18.6M
FY24
$24.2M
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Service revenue, net70%
Diagnostic Testing30%
By geography

Not disclosed.

The read

Precipio, Inc. booked $24.2M in FY2025 revenue, growing 31% year over year — faster than most Healthcare companies we track, at a -1.5% net margin.

Peers · Healthcare
Interpace Biosciences, Inc.74BINmune Bio, Inc.41DDecibel Cannabis Company Inc.62CTelomir Pharmaceuticals, Inc. Common Stock——
Neighbors
New Haven →
Veradermics, Incorporated——Trevi Therapeutics, Inc.——Biohaven Ltd.——Arvinas, Inc.$262.6M62CRallybio Corporation$858.0k47DBioXcel Therapeutics, Inc.$642.0k27D
Key facts
CEOIlan Danieli
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersNew Haven, CT
ExchangeNASDAQ: PRPO
Employees54
IPO date2017-06-30
Latest filings
8-K2026-06-1510-Q2026-05-148-K2026-05-06DEF 14A2026-04-2810-K2026-03-308-K2026-02-278-K2025-12-2910-Q2025-11-14
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.
HomeScreenerChatCompanies